2005Zhonghua shenjing waike zazhiRequires access

The effects of CDDP on the progress of apoptosis in glioma cell induced by TRAIL/APO-2L

Shi Mei

Open publisher page 1 citations

Abstract

Objective To investigate the effects of TRAIL on apoptosis in human glioma cell line and study the mechanism of CDDP on apoptotic process induced by TRAIL . Methods Different doses of CDDP was added in the media of glioma cells with treatment of different doses of TRAIL, then viability was examined by MTT assay. Afterwards, sub-poisonous dose of TRAIL and CDDP were added into media of glioma cells, the apoptotic percentages of three experimental groups that included the TRAIL, CDDP and TRAIL-CDDP groups were examined by FCM. Western blot assay was used to examine the expression of DR5 with or without CDDP. Results Within a certain time, when the doses of TRAIL and CDDP increased, the viability of U251 glioma cell became lower synchronously. The viability of glioma cells induced by TRAIL, CDDP and TRAIL-CDDP which were 50 ng·ml -1 and 4μg·ml -1and 50 ng·ml -1- 4μg·ml -1 were 72.43% , 75.56% and 23.45%,respectively. The apoptotic percentages of glioma cells induced by TRAIL, CDDP and TRAIL-CDDP were 25.61%,20.59% and 62.33%, respectively. The apoptotic percentages of glioma cells induced by CDDP and TRAIL were significantly lower than that by TRAIL-CDDP(P0.01). Western blot showed that the expression of DR5 of cells with CDDP was higher than that without CDDP. The expression of DR5 was increased gradually within certain time. Conclusions The apoptosis of glioma cell induced by TRAIL-CDDP was significantly higher than that of cells treated by TRAIL or CDDP solely. The mechanism may be that the expression of DR5 was up-regulated by CDDP.

About this research paper

What this paper is about

Objective To investigate the effects of TRAIL on apoptosis in human glioma cell line and study the mechanism of CDDP on apoptotic process induced by TRAIL . Methods Different doses of CDDP was added in the media of glioma cells with treatment of different doses of TRAIL, then viability was examined by MTT assay. Afterwards, sub-poisonous dose of TRAIL and CDDP were added into media of glioma cells, the apoptotic percentages of three experimental groups that included the TRAIL, CDDP and TRAIL-CDDP groups were examined by FCM. Western blot assay was used to examine the expression of DR5 with or without CDDP. Results Within a certain time, when the doses of TRAIL and CDDP increased, the viability of U251 glioma cell became lower synchronously. The viability of glioma cells induced by TRAIL, CDDP and TRAIL-CDDP which were 50 ng·ml -1 and 4μg·ml -1and 50 ng·ml -1- 4μg·ml -1 were 72.43% , 75.56% and 23.45%,respectively. The apoptotic percentages of glioma cells induced by TRAIL, CDDP and TRAIL-CDDP were 25.61%,20.59% and 62.33%, respectively. The apoptotic percentages of glioma cells induced by CDDP and TRAIL were significantly lower than that by TRAIL-CDDP(P0.01). Western blot showed that the expression of DR5 of cells with CDDP was higher than that without CDDP. The expression of DR5 was increased gradually within certain time. Conclusions The apoptosis of glioma cell induced by TRAIL-CDDP was significantly higher than that of cells treated by TRAIL or CDDP solely. The mechanism may be that the expression of DR5 was up-regulated by CDDP.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effects of TRAIL on apoptosis in human glioma cell line and study the mechanism of CDDP on apoptotic process induced by TRAIL . Methods Different doses of CDDP was added in the media of glioma cells with treatment of different doses of TRAIL, then viability was examined by MTT assay. Afterwards, sub-poisonous dose of TRAIL and CDDP were added into media of glioma cells, the apoptotic percentages of three experimental groups that included the TRAIL, CDDP and TRAIL-CDDP groups were examined by FCM. Western blot assay was used to examine the expression of DR5 with or without CDDP. Results Within a certain time, when the doses of TRAIL and CDDP increased, the viability of U251 glioma cell became lower synchronously. The viability of glioma cells induced by TRAIL, CDDP and TRAIL-CDDP which were 50 ng·ml -1 and 4μg·ml -1and 50 ng·ml -1- 4μg·ml -1 were 72.43% , 75.56% and 23.45%,respectively. The apoptotic percentages of glioma cells induced by TRAIL, CDDP and TRAIL-CDDP were 25.61%,20.59% and 62.33%, respectively. The apoptotic percentages of glioma cells induced by CDDP and TRAIL were significantly lower than that by TRAIL-CDDP(P0.01). Western blot showed that the expression of DR5 of cells with CDDP was higher than that without CDDP. The expression of DR5 was increased gradually within certain time. Conclusions The apoptosis of glioma cell induced by TRAIL-CDDP was significantly higher than that of cells treated by TRAIL or CDDP solely. The mechanism may be that the expression of DR5 was up-regulated by CDDP.

Key concepts: Glioma, Apoptosis, Viability assay, MTT assay, Western blot, Chemistry, Cancer research, Cell culture

Related papers

Back to paper searchBrowse research topicsOriginal source
The effects of CDDP on the progress of apoptosis in glioma cell induced by TRAIL/APO-2L — Research Paper | ScholarLens